Calpain 3: a key regulator of the sarcomere?

Calpain 3 is a 94‐kDa calcium‐dependent cysteine protease mainly expressed in skeletal muscle. In this tissue, it localizes at several regions of the sarcomere through binding to the giant protein, titin. Loss‐of‐function mutations in the calpain 3 gene have been associated with limb‐girdle muscular dystrophy type 2A (LGMD2A), a common form of muscular dystrophy found world wide. Recently, significant progress has been made in understanding the mode of regulation and the possible function of calpain 3 in muscle. It is now well accepted that it has an unusual zymogenic activation and that cytoskeletal proteins are one class of its substrates. Through the absence of cleavage of these substrates, calpain 3 deficiency leads to abnormal sarcomeres, impairment of muscle contractile capacity, and death of the muscle fibers. These data indicate a role for calpain 3 as a chef d'orchestre in sarcomere remodeling and suggest a new category of LGMD2 pathological mechanisms.

[1]  D. E. Goll,et al.  The calpain system. , 2003, Physiological reviews.

[2]  L. Peltonen,et al.  Secondary calpain3 deficiency in 2q-linked muscular dystrophy , 2001, Neurology.

[3]  J. Beckmann,et al.  Calpain 3 mRNA expression in mice after denervation and during muscle regeneration. , 2001, American journal of physiology. Cell physiology.

[4]  Chien-Chang Chen,et al.  Defective membrane repair in dysferlin-deficient muscular dystrophy , 2003, Nature.

[5]  H. Sorimachi,et al.  Newly identified exons encoding novel variants of p94/calpain 3 are expressed ubiquitously and overlap the α‐glucosidase C gene , 2003, FEBS letters.

[6]  P. Davies,et al.  Ca2+ dependency of calpain 3 (p94) activation. , 2006, Biochemistry.

[7]  M. Yamazaki,et al.  Effects of Serum Deprivation on Expression of Proteolytic-Related Genes in Chick Myotube Cultures , 2005, Bioscience, biotechnology, and biochemistry.

[8]  O. Pourquié,et al.  Expression of genes (CAPN3, SGCA, SGCB, and TTN) involved in progressive muscular dystrophies during early human development. , 1998, Genomics.

[9]  J. Beckmann,et al.  Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IκBα/NF-κB pathway in limb-girdle muscular dystrophy type 2A , 1999, Nature Medicine.

[10]  Wayne N Frankel,et al.  The muscular dystrophy with myositis (mdm) mouse mutation disrupts a skeletal muscle-specific domain of titin. , 2002, Genomics.

[11]  P. Davies,et al.  Active recombinant rat calpain II. Bacterially produced large and small subunits associate both in vivo and in vitro. , 1994, The Journal of biological chemistry.

[12]  D. Balcerzak,et al.  Evidence for implication of muscle-specific calpain (p94) in myofibrillar integrity. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[13]  I. Richard,et al.  Force impairment in calpain 3–deficient mice is not correlated with mechanical disruption , 2003, Muscle & nerve.

[14]  K Suzuki,et al.  Functional Defects of a Muscle-specific Calpain, p94, Caused by Mutations Associated with Limb-Girdle Muscular Dystrophy Type 2A* , 1998, The Journal of Biological Chemistry.

[15]  J. Beckmann,et al.  Loss of Calpain 3 Proteolytic Activity Leads to Muscular Dystrophy and to Apoptosis-Associated Iκbα/Nuclear Factor κb Pathway Perturbation in Mice , 2000, The Journal of cell biology.

[16]  C. Garcı́a-Martı́nez,et al.  Calpain-3 gene expression is decreased during experimental cancer cachexia. , 2000, Biochimica et biophysica acta.

[17]  M. Vorgerd,et al.  Limb girdle muscular dystrophy in a sibling pair with a homozygous Ser606Leu mutation in the alternatively spliced IS2 region of calpain 3 , 2005, Biological chemistry.

[18]  H. Sorimachi,et al.  Muscle-specific Calpain, p94, Responsible for Limb Girdle Muscular Dystrophy Type 2A, Associates with Connectin through IS2, a p94-specific Sequence (*) , 1995, The Journal of Biological Chemistry.

[19]  J. Beckmann,et al.  Expression and Functional Characteristics of Calpain 3 Isoforms Generated through Tissue-Specific Transcriptional and Posttranscriptional Events , 1999, Molecular and Cellular Biology.

[20]  I. Richard,et al.  Safety and efficacy of AAV-mediated calpain 3 gene transfer in a mouse model of limb-girdle muscular dystrophy type 2A. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[21]  S. Lecker,et al.  Ubiquitin-protein ligases in muscle wasting. , 2005, The international journal of biochemistry & cell biology.

[22]  Isabelle Richard,et al.  Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A , 1995, Cell.

[23]  J. Beckmann,et al.  Limb-girdle muscular dystrophy in Guipúzcoa (Basque Country, Spain). , 1998, Brain : a journal of neurology.

[24]  J. Beckmann,et al.  Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A. , 1998, The American journal of pathology.

[25]  R. Horowits The physiological role of titin in striated muscle. , 1999, Reviews of physiology, biochemistry and pharmacology.

[26]  M. Aoki,et al.  Expression of tropism-related genes in regenerating skeletal muscle of rats treated with cyclosporin-A , 2005, Cell and Tissue Research.

[27]  H. Kawasaki,et al.  Purification of native p94, a muscle-specific calpain, and characterization of its autolysis. , 1998, The Biochemical journal.

[28]  E. McNally,et al.  The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. , 2004, Circulation research.

[29]  Leena Peltonen,et al.  Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin. , 2002, American journal of human genetics.

[30]  M. Zatz,et al.  The effect of calpain 3 deficiency on the pattern of muscle degeneration in the earliest stages of LGMD2A , 2003, Journal of clinical pathology.

[31]  J. Beckmann,et al.  Chromosome 15-linked limb-girdle muscular dystrophy: Clinical phenotypes in Reunion Island and French metropolitan communities , 1996, Neuromuscular Disorders.

[32]  N. Bourg,et al.  Calpain 3 Is Activated through Autolysis within the Active Site and Lyses Sarcomeric and Sarcolemmal Components , 2003, Molecular and Cellular Biology.

[33]  Z. Jia,et al.  Crystal structure of calpain reveals the structural basis for Ca2+‐dependent protease activity and a novel mode of enzyme activation , 1999, The EMBO journal.

[34]  D. MacArthur,et al.  Limb–girdle muscular dystrophy: Diagnostic evaluation, frequency and clues to pathogenesis , 2008, Neuromuscular Disorders.

[35]  T. Saido,et al.  The behavior of calpain-generated N- and C-terminal fragments of talin in integrin-mediated signaling pathways. , 1999, Archives of biochemistry and biophysics.

[36]  D. Attaix,et al.  Altered responses in skeletal muscle protein turnover during aging in anabolic and catabolic periods. , 2005, The international journal of biochemistry & cell biology.

[37]  J. Beckmann,et al.  Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A. , 1999, Nature medicine.

[38]  R. Campbell,et al.  Homodimerization of calpain 3 penta-EF-hand domain. , 2005, The Biochemical journal.

[39]  J. Beckmann,et al.  Stable expression of calpain 3 from a muscle transgene in vivo: Immature muscle in transgenic mice suggests a role for calpain 3 in muscle maturation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[40]  I. Richard,et al.  Down-regulation of genes in the lysosomal and ubiquitin-proteasome proteolytic pathways in calpain-3-deficient muscle. , 2003, The international journal of biochemistry & cell biology.

[41]  G. Lamb,et al.  mu-Calpain and calpain-3 are not autolyzed with exhaustive exercise in humans. , 2006, American journal of physiology. Cell physiology.

[42]  H. Sorimachi,et al.  A novel aspect of calpain activation , 1998, FEBS letters.

[43]  E. Kudryashova,et al.  Mdm muscular dystrophy: interactions with calpain 3 and a novel functional role for titin's N2A domain. , 2005, Human molecular genetics.

[44]  J. Beckmann,et al.  Mutations in calpain 3 associated with limb girdle muscular dystrophy: analysis by molecular modeling and by mutation in m-calpain. , 2001, Biophysical journal.

[45]  P. Davies,et al.  The protease core of the muscle‐specific calpain, p94, undergoes Ca2+‐dependent intramolecular autolysis , 2002, FEBS letters.

[46]  I. Nishino,et al.  Localization of calpain 3 in human skeletal muscle and its alteration in limb-girdle muscular dystrophy 2A muscle. , 2003, Journal of biochemistry.

[47]  K. Bushby,et al.  The phenotype of calpainopathy: diagnosis based on a multidisciplinary approach , 2001, Neuromuscular Disorders.

[48]  H. Sorimachi,et al.  A Novel Ligand for CD44 Is Serglycin, a Hematopoietic Cell Lineage-specific Proteoglycan , 1995, The Journal of Biological Chemistry.

[49]  C. Angelini,et al.  Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression. , 2003, The American journal of pathology.

[50]  M. Yano,et al.  Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. , 1996, The Journal of clinical investigation.

[51]  H. Kawasaki,et al.  Muscle-specific calpain, p94, is degraded by autolysis immediately after translation, resulting in disappearance from muscle. , 1993, The Journal of biological chemistry.

[52]  M. Hermanová,et al.  Mutations in Czech LGMD2A patients revealed by analysis of calpain3 mRNA and their phenotypic outcome , 2004, Neuromuscular Disorders.

[53]  E. Kudryashova,et al.  Calpain 3 participates in sarcomere remodeling by acting upstream of the ubiquitin-proteasome pathway. , 2005, Human molecular genetics.

[54]  J. Beckmann,et al.  Calpain 3 cleaves filamin C and regulates its ability to interact with gamma- and delta-sarcoglycans. , 2003, Muscle & nerve.

[55]  J. Beckmann,et al.  A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B , 1998, Nature Genetics.

[56]  Z. Jia,et al.  A Ca2+ Switch Aligns the Active Site of Calpain , 2002, Cell.

[57]  J. Beckmann,et al.  Calpain 3 cleaves filamin C and regulates its ability to interact with γ‐ and δ‐sarcoglycans , 2003 .

[58]  C. Denis,et al.  Molecular adaptations of neuromuscular disease‐associated proteins in response to eccentric exercise in human skeletal muscle , 2002, The Journal of physiology.

[59]  N. Kanzawa,et al.  A novel domain sequence of connectin localized at the I band of skeletal muscle sarcomeres: homology to neurofilament subunits. , 1993, Biochemical and biophysical research communications.

[60]  H. Kawasaki,et al.  Molecular cloning of a novel mammalian calcium-dependent protease distinct from both m- and mu-types. Specific expression of the mRNA in skeletal muscle. , 1989, The Journal of biological chemistry.

[61]  R. Campbell,et al.  Insertion Sequence 1 of Muscle-specific Calpain, p94, Acts as an Internal Propeptide* , 2004, Journal of Biological Chemistry.

[62]  B. Yaspan,et al.  Calpain cleavage promotes talin binding to the beta 3 integrin cytoplasmic domain. , 2001, The Journal of biological chemistry.

[63]  K. Suzuki,et al.  Muscle-specific calpain, p94, interacts with the extreme C-terminal region of connectin, a unique region flanked by two immunoglobulin C2 motifs. , 1997, Archives of biochemistry and biophysics.

[64]  E. Kudryashova,et al.  Null mutation of calpain 3 (p94) in mice causes abnormal sarcomere formation in vivo and in vitro. , 2004, Human molecular genetics.

[65]  K. Mathews,et al.  Limb-girdle muscular dystrophy , 2003, Current neurology and neuroscience reports.

[66]  K. Bushby,et al.  Protein studies in dysferlinopathy patients using llama-derived antibody fragments selected by phage display , 2005, European Journal of Human Genetics.

[67]  C. Angelini,et al.  The frequency of limb girdle muscular dystrophy 2A in northeastern Italy , 2005, Neuromuscular Disorders.

[68]  N. Forsberg,et al.  Role of calpain in skeletal-muscle protein degradation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[69]  I. Richard,et al.  Calpains in muscle wasting. , 2005, The international journal of biochemistry & cell biology.

[70]  I. Nonaka,et al.  Calpain 3 gene mutations: genetic and clinico-pathologic findings in limb-girdle muscular dystrophy , 2001, Neuromuscular Disorders.